Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Somatostatin peptides prepared by Novartis

Feb. 28, 1997

Yamanouchi prepares hormonal agents for testosterone-dependent disorders

Feb. 28, 1997

Cytotoxic colchicine derivatives from Indena

Feb. 27, 1997

Third pivotal trial for lisofylline

Feb. 26, 1997

New approach to brain cancer introduced

Feb. 26, 1997

U.S. researchers reveal agents for reversing MDR

Feb. 25, 1997

Oxford GlycoSciences describes pyrimidine-based glycoconjugates

Feb. 25, 1997

SCRAS discloses novel topoisomerase inhibitors

Feb. 25, 1997

NIH seeks licensees for cancer vaccines

Feb. 24, 1997

CD40 ligands and MAbs offered for licensing

Feb. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...